CN Patent

CN104684555A — 囊泡单胺转运体2的氘化苯并喹啉抑制剂的制剂药代动力学

Assigned to Auspex Pharmaceuticals Inc · Expires 2015-06-03 · 11y expired

What this patent protects

本发明涉及包含苯并喹啉化合物的新型药物组合物，以及抑制受试者体内囊泡单胺转运体2(VMAT2)活性以用于治疗慢性运动机能亢进性运动障碍的方法。

USPTO Abstract

本发明涉及包含苯并喹啉化合物的新型药物组合物，以及抑制受试者体内囊泡单胺转运体2(VMAT2)活性以用于治疗慢性运动机能亢进性运动障碍的方法。

Drugs covered by this patent

valbenazine-tosylate (VALBENAZINE TOSYLATE)

Patent Metadata

Patent number: CN104684555A
Jurisdiction: CN
Classification: —
Expires: 2015-06-03
Drug substance claim: No
Drug product claim: No
Assignee: Auspex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.